SARS-CoV-2 nanobodies 2.0.

Labroussaa, Fabien; Jores, Joerg

Labroussaa, Fabien; Jores, Joerg.

Labroussaa F; Institute of Veterinary Bacteriology, Department of Infectious Diseases and Pathobiology, University of Bern, Bern, Switzerland.
Jores J; Institute of Veterinary Bacteriology, Department of Infectious Diseases and Pathobiology, University of Bern, Bern, Switzerland. joerg.jores@vetsuisse.unibe.ch.

Signal Transduct Target Ther ; 6(1): 202, 2021 05 22.

Article in English | MEDLINE | ID: covidwho-1387228

Subject(s)

COVID-19; Single-Domain Antibodies; Antibodies, Neutralizing; Humans; SARS-CoV-2; Spike Glycoprotein, Coronavirus

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Single-Domain Antibodies / COVID-19 Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2021 Document Type: Article Affiliation country: S41392-021-00632-1

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google